Dr. Matthias Hackl

Dr. Matthias Hackl is the co-founder and CEO of TAmiRNA GmbH, which was founded in 2013 in Vienna, Austria. He holds a Ph.D. in biotechnology and, before co-founding TAmiRNA, led several genomic research projects in academia (University of Natural Resources and Life Sciences Vienna (BOKU)), including fellowships at the University of Minnesota and University Bielefeld to decipher the non-coding RNA transcriptome in mammalian cell lines. He has several years of experience in in vitro diagnostics development with a focus on microRNA biomarkers in liquid biopsies. At TAmiRNA Dr. Hackl and his team are currently developing applications of microRNA biomarkers in the area of bone, cardiovascular, and liver disease, toxicology, and cellular senescence. Dr. Hackl has received Young Investigator Awards from ASBMR and ECTS for work on microRNA biomarker discovery and validation in osteoporosis and has received several national entrepreneurship awards.